Becton Dickinson & (BDX)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BECTON DICKINSON & CO (BDX) CIK: 0000010795 --- Reporting Owner --- Name: Goette Roland CIK: 0001708067 Role: Officer (EVP and President, EMEA) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-11 | Code: S (Open market sale) Shares: -2,438 | Price: $180.84 Total Value: $440,887.92 Shares Owned After: 14,856 | Ownership: D (Direct) Footnotes: [F1] Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). [F2] Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) Footnotes: [F3] Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of August 3, 2026. --- Footnotes (Complete Index) --- F1: Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). F2: Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. F3: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of August 3, 2026. --- Signature --- /s/ Donna Kalazdy, by power of attorney from Roland Goette (2026-08-12)